Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region
Authors:
Open Access
- 1 May 1997
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 323 (3) , 777-783
Abstract
A number of mutants with single amino acid replacements were generated in the highly conserved ATP-binding cassette (ABC)-signature region (amino acids 531–543) of the N-terminal half of the human multidrug resistance (MDR1) protein. The cDNA variants were inserted into recombinant baculoviruses and the MDR1 proteins were expressed in Spodoptera frugiperda (Sf9) insect cells. The level of expression and membrane insertion of the MDR1 variants was examined by immunostaining, and MDR1 function was followed by measuring drug-stimulated ATPase activity. We found that two mutations, L531R and G534V, practically eliminated MDR1 expression; thus these amino acid replacements seem to inhibit the formation of a stable MDR1 protein structure. The MDR1 variants G534D and I541R were expressed at normal levels with normal membrane insertion, but showed a complete loss of drug-stimulated ATPase activity, while mutant R538M yielded full protein expression but with greatly decreased ATPase activity. Increasing the ATP concentration did not restore MDR1 ATPase activity in these variants. Some amino acid replacements in the ABC-signature region (K536I, K536R, I541T and R543S) affected neither the expression and membrane insertion nor the ATPase function of MDR1. We found no alteration in the drug-sensitivity of ATP cleavage in any of the MDR1 variants that had measurable ATPase activity. These observations suggest that the ABC-signature region is essential for MDR1 protein stability and function, but alterations in this region do not seem to modulate MDR1–drug interactions directly.Keywords
This publication has 24 references indexed in Scilit:
- Mutations within the first LSGGQ motif of Ste6p cause defects in a-factor transport and mating in Saccharomyces cerevisiaeJournal of Bacteriology, 1996
- A serine-to-arginine (AGT-to-CGT) mutation in codon 549 of the CFTR gene in an Italian patient with severe cystic fibrosisGenomics, 1991
- Structural model of the nucleotide-binding conserved component of periplasmic permeases.Proceedings of the National Academy of Sciences, 1991
- Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.Proceedings of the National Academy of Sciences, 1990
- Structural model of ATP-binding proteing associated with cystic fibrosis, multidrug resistance and bacterial transportNature, 1990
- A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator proteinNature, 1990
- Expression of the human multidrug transporter in insect cells by a recombinant baculovirusBiochemistry, 1990
- Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporterBiochemical and Biophysical Research Communications, 1990
- Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.Molecular and Cellular Biology, 1989
- Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.Proceedings of the National Academy of Sciences, 1986